International Journal of Infectious Diseases and Therapy
Volume 5, Issue 1, March 2020, Pages: 1-3
Received: Jan. 13, 2020;
Accepted: Jan. 27, 2020;
Published: Feb. 12, 2020
Views 477 Downloads 100
Mazo Koné, Department of Zoology, University of Ibadan, Ibadan, Nigeria; PA&KA Medical Laboratory, Bamako, Mali
Henrietta Oluwatoyin Awobode, Department of Zoology, University of Ibadan, Ibadan, Nigeria
Henrietta Oluwatoyin Awobode,
Co-infection of Toxoplasma gondii and HIV Infections in Pregnancy in Bamako - A Case Report, International Journal of Infectious Diseases and Therapy.
Vol. 5, No. 1,
2020, pp. 1-3.
M. L. Dardé, D. Ajzenberg, and J. Smith, “Population structure and epidemiology of toxoplasma gondii,” in Toxoplasma Gondii, 2007.
J. P. Dubey, Toxoplasmosis of Animals and Humans. 2016.
G. Shen, X. Wang, H. Sun, and Y. Gao, “Seroprevalence of Toxoplasma gondii infection among HIV/AIDS patients in Eastern China,” Korean J. Parasitol., vol. 54, no. 1, pp. 93–96, Feb. 2016.
https://www.cdc.gov/, “Opportunistic Infections | Living with HIV | HIV Basics | HIV/AIDS | CDC,” Opportunistic Infections, 2017. [Online]. Available: https://www.cdc.gov/hiv/basics/livingwithhiv/opportunisticinfections.html. [Accessed: 03-Jan-2020].
S. B. Porter and M. A. Sande, “Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome,” N. Engl. J. Med., 1992.
B. Grimwood, G. O’Connor, and H. A. Gaafar, “Toxofactor associated with Toxoplasma gondii infection is toxic and teratogenic to mice,” Infect. Immun., 1983.
A. Trundley and A. Moffett, “Human uterine leukocytes and pregnancy,” Tissue Antigens. 2004.
T. Manjavidze, C. Rylander, F. E. Skjeldestad, N. Kazakhashvili, and E. E. Anda, “Incidence and causes of perinatal mortality in Georgia,” J. Epidemiol. Glob. Health, vol. 9, no. 3, pp. 163–168, 2019.
M. C. Sirin et al., “Seroprevalence of Toxoplasma gondii, Rubella virus and Cytomegalovirus among pregnant women and the importance of avidity assays,” Saudi Med. J., vol. 38, no. 7, pp. 727–732, 2017.
Z. D. Wang et al., “Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis,” Lancet HIV, vol. 4, no. 4, pp. e177–e188, Apr. 2017.
M. Rouatbi et al., “Toxoplasma gondii infection and toxoplasmosis in North Africa: A review,” Parasite, vol. 26, no. 2019. 2019.
A. Rostami et al., “Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis.,” PLoS Negl. Trop. Dis., vol. 13, no. 10, p. e0007807, Oct. 2019.
A. R. Prusa, M. Hayde, L. Unterasinger, A. Pollak, K. R. Herkner, and D. C. Kasper, “Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection,” Diagn. Microbiol. Infect. Dis., 2010.
F. Leslé, F. Touafek, A. Fekkar, D. Mazier, and L. Paris, “Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: Interest of Toxo IgG Western blot,” Eur. J. Clin. Microbiol. Infect. Dis., 2011.
J. Van Helden, “Performance of Elecsys® Toxo IgG and IgM immunoassays,” Clin. Lab., 2009.
P. Sharma and K. Khuc, “Summary Basis for Regulatory Action Template I concur with the summary review. □ I concur with the summary review and include a separate review to add further analysis. □ I do not co review. ncur with the summary review and include a separate,” Rev. Off. Signatory Auth., 2018.
G. Gebremicael et al., “The performance of BD FACSPrestoTM for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia,” PLoS One, 2017.
P. Meylan, L. Paris, and O. Liesenfeld, “Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii,” Eur. J. Microbiol. Immunol., vol. 5, no. 2, pp. 150–158, 2015.